Skip to main content
Veterinary Medicines

Albipen L.A. 100 mg/ml Suspensie voor injectie

Authorised
  • Ampicillin

Product identification

Medicine name:
Albipen L.A. 100 mg/ml Suspensie voor injectie
Albipen L.A. 100 mg/ml Suspension injectable
Albipen L.A. 100 mg/ml Injektionssuspension
Active substance:
  • Ampicillin
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Ampicillin
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • All relevant tissues
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CA01
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Package description:
  • Albipen L.A. 200 ml PET Vial Suspension for injection
  • Albipen L.A. 80 ml PET Vial Suspension for injection
  • Albipen L.A. 200 ml glass Vial Suspension for injection
  • Albipen L.A. 80 ml glass Vial Suspension for injection
  • Albipen L.A. 30 ml glass Vial Suspension for injection

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet Productions S.r.l.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 9/11/2023
French (PDF)
Published on: 9/11/2023

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 9/11/2023
French (PDF)
Published on: 9/11/2023
German (PDF)
Published on: 9/11/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."